HUMPHREY RACHEL

Track

Insider profile

HUMPHREY RACHEL's trades of Pyxis Oncology Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
95.46
Quantity 25,142 +18.5%
Value US$3,722,616
Transaction date
Proposed sale
Price
473.43
Quantity 45,473
Value US$120,784
Transaction date
Planned sale
Price
368.83
Quantity 57,021 -5.7%
Value US$1,649,777
Transaction date
Proposed sale
Price
0.97
Quantity 200
Value US$194
Transaction date
Planned sale
Price
0.97
Quantity 1,400 -1.4%
Value US$1,362
Transaction date
Proposed sale
Price
0.97
Quantity 1,400
Value US$1,362
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-25 2025-04-21
PlS Planned sale
25,142 +18.5%
95.46
US$3,722,616 		25,142 +18.5% 95.46 US$3,722,616
2025-04-21 2025-04-21
PrS Proposed sale
45,473
473.43
US$120,784 		45,473 473.43 US$120,784
2026-03-25 2025-04-17
PlS Planned sale
57,021 -5.7%
368.83
US$1,649,777 		57,021 -5.7% 368.83 US$1,649,777
2025-04-17 2025-04-17
PrS Proposed sale
200
0.97
US$194 		200 0.97 US$194
2026-03-25 2025-04-14
PlS Planned sale
1,400 -1.4%
0.97
US$1,362 		1,400 -1.4% 0.97 US$1,362
2025-04-14 2025-04-14
PrS Proposed sale
1,400
0.97
US$1,362 		1,400 0.97 US$1,362